Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Gattermann

Showing results (21-30 of 109) with videos related to

Pageof 11
Sort By:
Leukemia|June 13, 2008
Improving the prognostic evaluation of patients with lower risk myelodysplastic syndromesA Kuendgen, N Gattermann, U Germing
Leukemia & Lymphoma|September 14, 2004
Risk assessment in chronic myelomonocytic leukemia (CMML)U Germing, A Kündgen, N Gattermann
Haematology and Blood Transfusion|January 1, 1990
Risk of leukemic transformation in two types of acquired idiopathic sideroblastic anemiaN Gattermann, C Aul, W Schneider
Blood|August 1, 1992
Comparison of in vitro growth characteristics of blast cell progenitors (CFU-L) in patients with myelodysplastic syndromes and acute myeloid leukemiaC Aul, N Gattermann, W Schneider
Blood|October 9, 1998
Antisense RNA crossing mitochondrial membrane?G Hofhaus, N Gattermann, J A Enríquez
Leukemia Research|January 4, 2001
Secondary myelodysplastic syndrome after fludarabine therapy of a low-grade non-Hodgkin's lymphomaE Misgeld, U Germing, C Aul, et al.
American Journal of Hematology|December 1, 1992
No large deletions of mitochondrial DNA in acquired idiopathic sideroblastic anemia (AISA)N Gattermann, H Lotz, C Aul, et al.
Annals of Hematology|May 23, 2003
Primary non-Hodgkin's lymphoma of bone: three cases and a short review of the literatureE Misgeld, A Wehmeier, O Krömeke, et al.
Deutsche Medizinische Wochenschrift (1946)|January 27, 2012
[Myelodysplastic syndromes (MDS)]U Germing, A Kündgen, R Haas, et al.
Deutsche Medizinische Wochenschrift (1946)|February 20, 1987
[Treatment of myelodysplastic syndromes]C Aul, A Heyll, N Gattermann, et al.
Pageof 11

Showing results (21-30 of 109) with videos related to

Sort By:
Pageof 11
Leukemia|June 13, 2008
Improving the prognostic evaluation of patients with lower risk myelodysplastic syndromesA Kuendgen, N Gattermann, U Germing
Leukemia & Lymphoma|September 14, 2004
Risk assessment in chronic myelomonocytic leukemia (CMML)U Germing, A Kündgen, N Gattermann
Haematology and Blood Transfusion|January 1, 1990
Risk of leukemic transformation in two types of acquired idiopathic sideroblastic anemiaN Gattermann, C Aul, W Schneider
Blood|August 1, 1992
Comparison of in vitro growth characteristics of blast cell progenitors (CFU-L) in patients with myelodysplastic syndromes and acute myeloid leukemiaC Aul, N Gattermann, W Schneider
Blood|October 9, 1998
Antisense RNA crossing mitochondrial membrane?G Hofhaus, N Gattermann, J A Enríquez
Leukemia Research|January 4, 2001
Secondary myelodysplastic syndrome after fludarabine therapy of a low-grade non-Hodgkin's lymphomaE Misgeld, U Germing, C Aul, et al.
American Journal of Hematology|December 1, 1992
No large deletions of mitochondrial DNA in acquired idiopathic sideroblastic anemia (AISA)N Gattermann, H Lotz, C Aul, et al.
Annals of Hematology|May 23, 2003
Primary non-Hodgkin's lymphoma of bone: three cases and a short review of the literatureE Misgeld, A Wehmeier, O Krömeke, et al.
Deutsche Medizinische Wochenschrift (1946)|January 27, 2012
[Myelodysplastic syndromes (MDS)]U Germing, A Kündgen, R Haas, et al.
Deutsche Medizinische Wochenschrift (1946)|February 20, 1987
[Treatment of myelodysplastic syndromes]C Aul, A Heyll, N Gattermann, et al.
Pageof 11